Retatrutide Clinical Trials

0
195

A. Weight Loss Benefits

Retatrutide has demonstrated substantial weight loss potential across multiple trials:

  • Phase 2 Trial (New England Journal of Medicine, 2023):
    A 48-week study involving 338 adults with obesity showed the following average weight reductions:
    • 1 mg dose: 8.7%
    • 4 mg dose: 17.1%
    • 8 mg dose: 22.8%
    • 12 mg dose: 24.2%
      (Placebo group: 2.1%)

Participants also experienced improvements in cholesterol levels, blood glucose, insulin sensitivity, and blood pressure.

  • Type 2 Diabetes Study:
    Adults with type 2 diabetes who received retatrutide (3/6/9/12 mg) lost an average of 17% of their body weight over nine months, with a favorable safety profile.
  • Preclinical Animal Studies:
    • Obese mice treated with retatrutide showed a 45% reduction in body weight through decreased fat mass and appetite suppression.
    • High-fat-fed mice exhibited reduced blood sugar levels and increased insulin concentrations after retatrutide administration.
  • Human Studies:
    In a Phase 1 study of 45 healthy individuals, subcutaneous retatrutide led to significant weight loss that was maintained up to 43 days.

B. Improved Blood Sugar Control

Retatrutide enhances blood sugar regulation by boosting insulin release and suppressing glucagon production. Evidence from trials includes:

  • Reduced HbA1c (a marker of long-term blood sugar control) in patients with type 2 diabetes.
  • Improved insulin sensitivity in obese mice, leading to lower fasting glucose levels.
  • Increased fasting insulin and C-peptide levels in human subjects, resulting in better glycemic control.

C. Blood Pressure Reduction

By promoting weight loss, retatrutide indirectly improves blood pressure—a common benefit linked to reduced body fat. Clinical findings include:

  • Phase 1 Trial: Participants experienced reductions in systolic blood pressure, which returned to near-baseline by day 29.
  • T2D Study: Diabetic patients treated with retatrutide for 12 weeks showed notable decreases in blood pressure alongside weight loss.

Know more about Retatrutide- https://olympicpeptide.com/product/retatrutide-10mg/

Zoeken
Werbung
Categorieën
Read More
Other
Space, Missile, and Warfighter Products Market to Reach US$ 18.0 Bn by 2034, Expanding at 5.6% CAGR Amid Rising Defense Spending and Technological Advancements
The global space, missile, and warfighter products market is entering a period of sustained...
By Mayur Gunjal 2026-08-21 09:46:04 0 16
Other
Pallet Stretch Wrapping Machine Market Grows with Rising Demand for Automated and Efficient Packaging Solutions
" According to the latest report published by Data Bridge Market Research, the Pallet...
By Rahul Rangwa 2026-08-21 09:14:26 0 31
Other
Concentrated Scalp Pastes Market Size, Share, Growth and Forecast 2026 to 2036
The global concentrated scalp pastes market is projected to reach USD 9.6 billion...
By Susmita Bhosale 2026-08-21 09:45:13 0 27
Networking
Neem Extracts Market: Insights and Competitive Analysis 2025 –2032
 According to the latest report published by Data Bridge Market Research, the Neem...
By Tweety Chincholkar 2026-08-21 09:39:38 0 4
Home
Global Electronics Cleaning Gel Market by Type, Distribution Channel, and Region: Forecast 2025–2031
The Electronics Cleaning Gel market is expected to register a CAGR of -.38% from 2026...
By Priya Deokar 2026-08-21 09:42:10 0 5